Massaeli H, Pierce G N
Ion Transport Laboratory, St. Boniface General Hospital Research Centre, University of Manitoba, Winnipeg, Canada.
Cardiovasc Res. 1995 May;29(5):597-603.
Low density lipoproteins have the capacity to alter cell calcium concentrations of a wide variety of cell types. The precise mechanism of physical interaction of the LDL or its products with the cell is not defined yet. There is more agreement about the calcium transport pathway affected. Most studies show an ability of LDL to alter transsarcolemmal calcium flux, probably through the slow calcium channel. However, internal stores of calcium like the sarcoplasmic reticulum also appear to be altered. These effects of LDL on cellular calcium homeostasis have potential importance in both physiological and disease settings. Oxidised LDL has even more potential significance than the native LDL in disease conditions. Free radical mediated oxidation of LDL during atherosclerotic and ischaemic conditions creates a molecule with even greater potency for altering cell calcium and ultimately cell function and viability. The interaction of this trio of compounds--LDL, free radicals, and cellular calcium--may be critical for the mechanism of pathogenesis in specific cardiovascular diseases. It will be important in the future to identify new therapeutic strategies to prevent their interaction.
低密度脂蛋白有能力改变多种细胞类型的细胞钙浓度。低密度脂蛋白及其产物与细胞之间物理相互作用的确切机制尚未明确。关于受影响的钙转运途径,人们的共识更多。大多数研究表明,低密度脂蛋白有能力改变跨肌膜钙通量,可能是通过慢钙通道。然而,像肌浆网这样的细胞内钙储存似乎也会发生改变。低密度脂蛋白对细胞钙稳态的这些影响在生理和疾病状态下都具有潜在的重要性。在疾病状态下,氧化型低密度脂蛋白比天然低密度脂蛋白具有更大的潜在意义。在动脉粥样硬化和缺血状态下,自由基介导的低密度脂蛋白氧化产生一种对改变细胞钙以及最终对细胞功能和活力具有更大效力的分子。这三种化合物——低密度脂蛋白、自由基和细胞钙——之间的相互作用可能对特定心血管疾病的发病机制至关重要。未来识别预防它们相互作用的新治疗策略将很重要。